QSAR studies on hepatitis C virus NS5A protein tetracyclic inhibitors in wild type and mutants by CoMFA and CoMSIA-Reference-Cited by-同舟云学术

QSAR studies on hepatitis C virus NS5A protein tetracyclic inhibitors in wild type and mutants by CoMFA and CoMSIA

Published:2020-03-25 Issue:4 Volume:31 Page:281-311
ISSN:1062-936X
Container-title:SAR and QSAR in Environmental Research
language:en
Short-container-title:SAR and QSAR in Environmental Research

Author:

Qin Z.¹,Yan A.¹

Affiliation:

1. State Key Laboratory of Chemical Resource Engineering, Department of Pharmaceutical Engineering, Beijing University of Chemical Technology, Beijing, PR China

Publisher

Informa UK Limited

Subject

Drug Discovery,Molecular Medicine,General Medicine,Bioengineering

Link

https://www.tandfonline.com/doi/pdf/10.1080/1062936X.2020.1740889

Reference38 articles.

1. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites

2. New Merck and Vertex drugs raise standard of care in hepatitis C

3. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies

4. Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase

5. Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Generation, QSAR, and Molecular Dynamic Simulation Studies for Virtual Screening of DNA Polymerase Theta Inhibitors;Current Computer-Aided Drug Design;2024-05-22

2. QSAR-Based Stacked Ensemble Classifier for Hepatitis C NS5B Inhibitor Prediction;2023 2nd International Conference on Computer System, Information Technology, and Electrical Engineering (COSITE);2023-08-02

3. Structure-based design, drug-likeness, and pharmacokinetic studies of novel substituted pyrimidine derivatives as potent HCV NS3/A4 protease inhibitors;Biocatalysis and Agricultural Biotechnology;2022-11

4. In silico design and pharmacokinetics investigation of some novel hepatitis C virus NS5B inhibitors: pharmacoinformatics approach;Bulletin of the National Research Centre;2022-04-15

5. Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions;Future Journal of Pharmaceutical Sciences;2021-10-29